Immix Biopharma, Inc.IMMXNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank60
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-28.35%
↑ 75% vs avg
Percentile
P60
Within normal range
Streak
2 yr
Consecutive growthAccelerating
Average
-115.32%
Historical baseline
PeriodValue
2024-28.35%
2023-53.50%
2022-366.13%
2021-292.72%
202048.77%
20190.00%